Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury
Fatih Arslan, Ruenn Chai Lai, Mirjam B Smeets, Lars Akeroyd, Andre Choo, Eissa N E Aguor, Leo Timmers, Harold V van Rijen, Pieter A Doevendans, Gerard Pasterkamp, Sai Kiang Lim, Dominique P de Kleijn, Fatih Arslan, Ruenn Chai Lai, Mirjam B Smeets, Lars Akeroyd, Andre Choo, Eissa N E Aguor, Leo Timmers, Harold V van Rijen, Pieter A Doevendans, Gerard Pasterkamp, Sai Kiang Lim, Dominique P de Kleijn
Abstract
We have previously identified exosomes as the paracrine factor secreted by mesenchymal stem cells. Recently, we found that the key features of reperfusion injury, namely loss of ATP/NADH, increased oxidative stress and cell death were underpinned by proteomic deficiencies in ischemic/reperfused myocardium, and could be ameliorated by proteins in exosomes. To test this hypothesis in vivo, mice (C57Bl6/J) underwent 30 min ischemia, followed by reperfusion (I/R injury). Purified exosomes or saline was administered 5 min before reperfusion. Exosomes reduced infarct size by 45% compared to saline treatment. Langendorff experiments revealed that intact but not lysed exosomes enhanced viability of the ischemic/reperfused myocardium. Exosome treated animals exhibited significant preservation of left ventricular geometry and contractile performance during 28 days follow-up. Within an hour after reperfusion, exosome treatment increased levels of ATP and NADH, decreased oxidative stress, increased phosphorylated-Akt and phosphorylated-GSK-3β, and reduced phosphorylated-c-JNK in ischemic/reperfused hearts. Subsequently, both local and systemic inflammation were significantly reduced 24h after reperfusion. In conclusion, our study shows that intact exosomes restore bioenergetics, reduce oxidative stress and activate pro-survival signaling, thereby enhancing cardiac function and geometry after myocardial I/R injury. Hence, mesenchymal stem cell-derived exosomes are a potential adjuvant to reperfusion therapy for myocardial infarction.
Copyright © 2013 Elsevier B.V. All rights reserved.
Source: PubMed
即将进行的临床试验
-
Artvin Coruh University尚未招聘夏科玛丽牙病 (CMT)土耳其(türkiye)
-
University of Management and Technology Lahore尚未招聘
-
Regeneron Pharmaceuticals招聘中
-
Kirsehir Ahi Evran Universitesi尚未招聘虐待儿童 | 护理教育 | 儿童忽视 | 儿童性虐待
-
Lokman Hekim University尚未招聘
-
Imagion Biosystems, Inc.招聘中
-
Ankara City Hospital Bilkent招聘中分娩恐惧症 | 剖宫产 | LABOR PAİN土耳其(türkiye)
-
Örebro University, Sweden招聘中
-
Cairo University尚未招聘
-
Indiana University招聘中怀孕预防 | 男性避孕 | 避孕器具 | Prevention of Semen Exposure During Intercourse美国
-
Tianjin Medical University Cancer Institute and...尚未招聘套细胞淋巴瘤 (MCL) | 复发/难治性套细胞淋巴瘤 (MCL)中国